SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-20-090463
Filing Date
2020-08-04
Accepted
2020-08-04 20:36:34
Documents
2
Period of Report
2020-07-29

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 1461
2 EX-24 ex-24.htm EX-24 3403
  Complete submission text file 0001104659-20-090463.txt   6283
Mailing Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087
Business Address 5 RADNOR CORPORATE CENTER SUITE 500 100 MATSONFORD RD RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS INC (Issuer) CIK: 0001267813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5 RADNOR CORPORATE CENTER STE 500 100 MATSONFORD RD RADNOR PA 19087
Business Address
Austin Charles (Reporting) CIK: 0001820217 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36576 | Film No.: 201075278